Skip to main content
SpringerLink
Log in

Tubular and Metabolic Dysfunction Following Transplantation

  • Chapter
Book cover Suki and Massry’s THERAPY OF RENAL DISEASES AND RELATED DISORDERS

  • 293 Accesses

Abstract

Metabolic and tubular defects occurring after kidney transplantation are multifactorial and depend on 1) the degree of efficiency of the transplanted organ, 2) side effects of immunosuppressive drugs, 3) late effects of dialysis treatment (e.g., amyloidosis, bone changes), 4) coexistent diseases, often accompanying the kidney failure (e.g., HBV or HCV infection), and 5) consequences of acute and chronic rejections, which by themselves are inflammatory processes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Gutshe HU, Delz E, Lüneburg E, et al.: Effect of cyclosporine on the proximal tubular function of the rat kidney (abstract). Kidney Int 637, 1984.

    Google Scholar 

  2. Dieperink H, Starklint H, Leyssac PP: Nephrotoxicity of cyclosporine—an animal model of nephrotoxic effect of cyclosporine on overall renal and tubular function in conscious rats. In: BD Kahad, ed, Cyclosporine. Grune and Stratton, New York, p 520, 1984.

    Google Scholar 

  3. Battle DC, Gutterman C, Tarka J, Prasad R: Effect of short term cyclosporine A administration on urinary acidification. Clin Nephrol 25 (Suppl): 162–169, 1986.

    Google Scholar 

  4. Adu D, Michael J, Turney J, Master P: Hypercalcemia in cyclosporine treated renal allograft recipients. Lancet 2: 370–371, 1983.

    Article  PubMed  CAS  Google Scholar 

  5. Heering P, Grabensee B: Influence of cyclosporin A on renal tubular function after kidney transplantation. Nephron 59: 66–70, 1991.

    Article  PubMed  CAS  Google Scholar 

  6. Aguilera S, Deray, Desjobert H, et al.: Effects of cyclosporine on tubular acidification function in patients with idiopatic uveitis. Am J Nephrol 12: 425–430, 1992.

    Article  PubMed  CAS  Google Scholar 

  7. Gradowska L: Wydzielanie jonu wodorowego przez przes-zczepiona nerke. Pol Arch Med Wewn 61 (5): 373, 1979.

    PubMed  CAS  Google Scholar 

  8. Derfus BA, Carrera GF, Komorowski RM, Ryan LM: Severe arthropathy and osteopathy following combined renal pancreas transplantation. Transplantation 53: 678–681, 1992.

    Article  PubMed  CAS  Google Scholar 

  9. Nordal KP, Dahl E, Halse J, Aksnes L, Thomassen Y, Flatmark A: Aluminium metabolism and bone histology after kidney transplantation, a one year follow-up study. J Clin Endocrinol Metab 74 (5): 1140–1145, 1992.

    Article  PubMed  CAS  Google Scholar 

  10. Bertolone G, Anchiami M, Bonuci E, et al.: Dynamics of bone aluminium over one year of functioning renal graft. Nephron 64 (4): 540–546, 1993.

    Article  PubMed  CAS  Google Scholar 

  11. Agarwal S, Owen R: Tendinitis and tendon ruptures in succesful renal transplant recipients. Clin Orthop 252: 270–275, 1990.

    PubMed  Google Scholar 

  12. Partiff AM: Hypercalcemia hyperparathyroidism following renal transplantation: diferential diagnosis management and implications for cell population control in the parathyroid gland. Miner Electrolyte Metab 8: 92–112, 1982.

    Google Scholar 

  13. Reid IR: Pathogenesis and treatment of steroid osteoporosis. Clin Endocrinol 30: 83–103, 1989.

    Article  CAS  Google Scholar 

  14. Rude RK, Gruber HE, Oldham SB: Cortisone-induced osteoporosis, effect on bone adenylate cyclase. Miner Electrolyte Metab 19 (2): 71–77, 1993.

    PubMed  CAS  Google Scholar 

  15. Gallagher JA, Beresford JN, Mac Donald BR, Russell RG: Hormone target cell interactions in human bone. In: Christiansen et al., eds, Osteoporosis. Glostrup Hospital pp 431–439, 1984.

    Google Scholar 

  16. Cascio VLO, Bonucci V, Imbimbo E, et al.: Bone loss after glucocorticoid therapy. Calcif Tissue Int 36:435–438, 1984.

    Article  PubMed  Google Scholar 

  17. Russel RG, Graveley R, Skjodt H: The effects of cyclosporine A on bone end cartilagt.Br] Rheumatol 32 (Suppl 1): 42–46, 1993.

    Google Scholar 

  18. Bosch SA, Raymakers JA, Huber-Bruning O: Acute changes in calcium and bone metabolism during methylprenisolone pulse therapy in rheumatoid arthritis. Br J Rheumatol 27: 215–219, 1988.

    Article  PubMed  Google Scholar 

  19. Katz JA, Jee WS, Jaffe II, et al.: Prostaglandin E2 alleviates cyclosporine A induced bone loss in rats. J Bone Miner Res 7 (10): 191–200, 1992.

    Google Scholar 

  20. Briner VA, Landmann J, Brunner FP, Thiel G: Cyclosporin A induced transient rise in plasma alkaline phosphatase in kidney transplant patients. Transplant Int 6 (2): 99–107, 1993.

    Article  CAS  Google Scholar 

  21. Russel RG, Graveley R, Coxon F, Skjodt H, Del-Poco E, Elford P, Mackenzie A: Cyclosporine A mode of action and effects on bone and joint tissues. Scand J Rheumatol Suppl 95: 8–9, 1992.

    Google Scholar 

  22. Sato K, Satoni S, Oguma S, Ohkohchi N, Ozaki H: Relationship between aseptic necrosis of femoral head bone and immunosuppressive therapy, especially CsA administration. Nippon Geka Gakkai Zasshi 94 (8): 832–839, 1993.

    PubMed  CAS  Google Scholar 

  23. Lukert BP, Johnson BE, Robinson RG: Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss.,/ Bone Miner Res 7 (9): 1063–1069, 1992.

    Article  CAS  Google Scholar 

  24. Kunz D: Treatment of common osteoporosis with fluoride: current trends. Rev Rhum Mal Osteoartic 59: 39–45, 1992.

    Google Scholar 

  25. Olbricht T, Benkert G: Glucocorticoid-induced osteoporosis, pathogenesis, prevention and treatment with special regard to rheumatic disease. J Intern Med 234 (3): 237–244, 1993.

    Article  PubMed  CAS  Google Scholar 

  26. Papapoulos SE, Landsan JO, Bijvoet OL, et al.: The use of biphosphonates in the treatment of osteoporosis. Bone 13 (Suppl I): s41 - s49, 1992.

    Article  PubMed  CAS  Google Scholar 

  27. Kwan JT, Almond MK, Ewans K, Cunningham J: Changes in total body mineral content and regional bone mineral density in renal patients following renal transplantation. Miner Electrolyte Metab 18: 166–168, 1992.

    PubMed  CAS  Google Scholar 

  28. Talataj M, Gradowska L, Durlik M, et al.: Prevention of glucocorticoid-induced osteoporosis with 25-hydroxyvitamin D in kidney transplant patients. Abstracts, XXX Congress of EDTAP, 6, 1993.

    Google Scholar 

  29. Rosenbaum RW, Hruska KA, Kokor A, Anderson C, Slatopolsky E: Decreased phosphate reabsorption after renal transplantation: evidence for a mechanism independent of calcium and parathyroid hormone. Kidney Int 19: 568–578, 1981.

    Article  PubMed  CAS  Google Scholar 

  30. Graf H, Kovarik J, Stummvoll HK, Wolf A, Pinggerra WF: Handling of phosphate by the transplanted kidney. Proc Eur Dial Transplant Assoc 16: 624–628, 1979.

    PubMed  CAS  Google Scholar 

  31. Pabico RC, McKenna BA, Freeman RB: Renal function before and after unilateral nephrectomy in renal donors. Kidney Int 8: 166–175, 1975.

    Article  PubMed  CAS  Google Scholar 

  32. Markell NS, Altura BT, Barbour RL, Altura BK: Ionized and total magnesium levels in cyclosporine-treated renal transplant recipients; relationship with cholesterol and cyclosporine level. Clin Sci (Colch) 85 (3): 315–318, 1993.

    CAS  Google Scholar 

  33. Nozue T, Kobayashi A, Sako A, et al.: Evidence that cyclosporine causes both intracellular migration and inappropiate urinary excretion of magnesium in rats. Transplantation 55 (2): 346–349, 1993.

    Article  PubMed  CAS  Google Scholar 

  34. Stethi P, Brown EA, Maini RN, Gower PE: Renal transplantation for dialysis arthropathy. Lancet ii: 448–449, 1988.

    Google Scholar 

  35. Campistol JM, Ponz E, Munoz-Gomez J, Oppenheimer F, Ricard MJ, Vilardell J, Andreu J: Renal transplantation for dialysis amyloidosis. Transplant Proc 24: 118–119, 1992.

    PubMed  CAS  Google Scholar 

  36. Livneh A, Zemer D, Siegal B, Leor A, Sohar E, Pras M: Colchicine prevents kidney transplant amyloidosis in Familial Mediterranean Fever. Nephron 60:418–122, 1992.

    Article  PubMed  CAS  Google Scholar 

  37. Harrison KL, Alpers ChE, Daris CL: De novo amyloidosis in a renal allograft: a case report and review of the literature. Am J Kidney Dis 22: 468–476, 1993.

    PubMed  CAS  Google Scholar 

  38. Burack DA, Gryffith BP, Thompson ME, Kahl LE: Hyperuricemia and gout among heart transplant recipients receiving cyclosporine. Am J Med 42: 141–145, 1992.

    Article  Google Scholar 

  39. Delaney V, Sumrani N, Daskelakis P, Hong JH, Sommer BG: Hyperuricemia and gout in renal allograft recipients. Transplant Proc 24: 1773–1774, 1992.

    PubMed  CAS  Google Scholar 

  40. Lin HY, Rocher LL, Me Quillan MA, Schaltz S, Pallella TD, Fox IH: Cyclosporine-induced hyperuricemia and gout. N Engl J Med 321: 287–292, 1989.

    Article  PubMed  CAS  Google Scholar 

  41. Noordzij TC, Leunissen KML, Ven Hooff JP: Renal handling of urate and the incidence of gout arthritis during cyclosporine and duvetic ure. Transplantation 52: 64–66, 1991.

    Article  PubMed  CAS  Google Scholar 

  42. Marcen R, Gallego N, Gamez C, Orofino L, Ortuno J: Hyperuricemia after kidney transplantation in patients treated with cyclosporine. Am J Med 93: 354–355, 1992.

    Article  PubMed  CAS  Google Scholar 

  43. Julian BA, Guarles LD, Niemann KMW: Musculoskeletal complications after renal transplantation: pathogenesis and treatment. Am J Kidney Dis 19: 99–120, 1992.

    PubMed  CAS  Google Scholar 

  44. Marais GE, Larson KK: Rhabdomyolysis and acute renal failure induced by combination lovastatin and gemfibrozil therapy. Ann Intern Med 112: 228–230, 1990.

    Article  PubMed  CAS  Google Scholar 

  45. Abouna GM, Kumar MSA, Silva OSG, Samhan M, Cheriyan G, At Abdulla I., White AG: Reversal of myocardial dysfunction following renal transplantation. Transplant Proc 25: 1034–1035, 1993.

    PubMed  CAS  Google Scholar 

  46. Castelao AM, Grino JM, Anders E, Gliverent S, Seron D, Castineiras MJ, Roca M, Galceran JM, Gonzalez MT, Alisina J: HMGCoA reductase inhibitors lovastatin and simvastatin in the treatment of hypercholesterolemia after renal transplantation. Transplant Proc 25: 1043–1046, 1993.

    PubMed  CAS  Google Scholar 

  47. Yoshimura N, Oka T, Okamato M, Ohmori Y: The effect of Pravastatin on hyperlipidemia in renal transplant recipients. Transplantation 53: 94–99, 1992.

    Article  PubMed  CAS  Google Scholar 

  48. Nicholas ML, Alexandre GPJ: The evolution of hyperlipidemia late after renal transplantation. Proc Eur Dial Transplant Assoc 16: 339, 1979.

    PubMed  CAS  Google Scholar 

  49. Moore R, Thomas D, Morgan E, Wheeler D, Griffin P, Salaman J, Rees A: Abnormal lipid and lipoprotein profiles following renal transplantation. Transplant Proc 25: 1060–1061, 1993.

    PubMed  CAS  Google Scholar 

  50. Webb AT, Plant M, Reaveley DA, O’Donnell M, Luck VA, O’Connor B, Seed M, Brown EA: Lipid and lipoprotein (a) concentration in transplant patients.

    Google Scholar 

  51. Diamond JR: In: WF Keane, JH Stein, eds, Contemporary Issues in Nephrology. Vol 24: Lipids and Renal Disease. Churchill Livingstone, New York, 109–1, 1990.

    Google Scholar 

  52. Schmitz PG, Kasiske BL, O’Donnel MP, Keane WF: Lipids and progressive renal injury. Semin Nephrol 9: 354–369, 1989.

    PubMed  CAS  Google Scholar 

  53. Appel G: Lipid abnormalites in renal disease. Kidney Int 39: 169–183, 1991.

    Article  PubMed  CAS  Google Scholar 

  54. Scott J: Lipoprotein (a): trombogenesis linked to athero-genesis at last. Nature 341: 22–23, 1989.

    Article  PubMed  CAS  Google Scholar 

  55. Kostner GM, Avogaro P, Cazzolato G, Marth E, Bittolobon G, Quinci GB: Lipoprotein Lp (a) and the risk for myocardial infarction. Atherosclerosis 38: 51–61, 1991.

    Article  Google Scholar 

  56. Hopper J, Ryan P, Lee JC, Rosenman W: Lipoid nephrosis in 31 adult patients. Medicine (Baltimore) 49: 321–341, 1970.

    Article  Google Scholar 

  57. Curry RC, Roberts WC: Status of the coronary arteries in the nephrotic syndrome. Am J Med 63: 183–192, 1977.

    Article  PubMed  Google Scholar 

  58. Traindl O, Reaoling S, Frauz M, Watschinger B, Klauser R, Pidlich H, Widhelm K, Pohonka E, Kovorik J: Treatment of hyperlipidemic kidney graft recipients with Lovastatin: effect on LDL-cholesterol and lipoprotein (a). Nephron 62: 394–398, 1992.

    Article  PubMed  CAS  Google Scholar 

  59. Kasiske BL, Tortorice KL, Heim-Dilthoy KL, Goryance JM, Rao V: Lovastatin treatment of hypercholesterolemia in renal transplant recipients. Transplantation 49: 95, 1990.

    Article  PubMed  CAS  Google Scholar 

  60. Chueng AK, De Vault GA, Gregory MC: A perspective study on treatment of hypercholesterolemia with Lovastatin in renal transplant patients receiving cyclosporine. J Am Soc Nephrol 3: 1884–1891, 1993.

    Google Scholar 

  61. Knigkt RJ, Vathsala A, Schoeuberg L, Cornel S, Weinberg RB, Goldstein RA, Lewis RM, Van Buren CT, Kohen BD: Treatment of hyperlipidemia in renal transplant patients with gemfibrozil and dietary modification. Transplantation 53: 224–225, 1991.

    Google Scholar 

  62. Gill IS, Hodge EE, Novick AC, Steinmuller DR, Garred D: Impact of obesity on renal transplantation. Transplant Proc 25: 1047–1048, 1993.

    PubMed  CAS  Google Scholar 

  63. Holley JL, Shapiro R, Lopatin WB, Tzakis AG, Hakela TR, Starz TE: Obesity as a risk factor following cadaver renal transplantation. Transplantation 49: 387–389, 1990.

    Article  PubMed  CAS  Google Scholar 

  64. Flechner SM, Kolbeiusson ME, Tarn J, Lum B: The impact of body weight on cyclosporine pharmacokinetics in renal transplant recipients. Transplantation 47: 806–810, 1989.

    Article  PubMed  CAS  Google Scholar 

  65. Rao M, Jacob CK, Shastry JCM: Post-renal transplant diabetes mellitus—retrospective study. Nephrol Dial Transplant 7: 1039–1042, 1992.

    PubMed  CAS  Google Scholar 

  66. Basadonna G, Matas AJ, Nojarian JS: Kidney transplantation in diabetic patient: The University of Minnesota experience. Kidney Int 42:S-193-S-196,1992.

    Google Scholar 

  67. Ekstrand AV, Eriksson JG, Gronhagen-Riska C, Ahonen PJ, Groop LC: Insulin resistance and insulin deficiency in the pathogenesis of posttransplantation diabetes in man. Transplantation 53: 563–569, 1992.

    Article  PubMed  CAS  Google Scholar 

  68. Feinstein EI, Wanner Ch, Bohler J, Horl WH: Endocrine and metabolic disorders following kidney transplantation. Am J Nephrol 12: 363–368, 1992.

    Article  PubMed  CAS  Google Scholar 

  69. Hricik DE, Bartucci MR, Moir EJ, Mayes JT, Schulak JA: Effects of steroid withdrawal on posttransplant diabetes mellitus in cyclosporine-treated renal transplant recipients. Transplantation 51: 374–377, 1991.

    Article  PubMed  CAS  Google Scholar 

  70. Ruiz JO, Simmons RL, Callender CO, Kjellstrand CM, Buselmeier TJ, Nojerien JS: Steroid-induced diabetes in renal transplant patients: pathogenetic factors and prognosis Surgery 73: 759, 1973.

    PubMed  CAS  Google Scholar 

  71. Seemayer TA, Murphy GF, Marliss EB: Glucose tolerance in the rat. Diabetes 34: 1309, 1985.

    Article  PubMed  Google Scholar 

  72. Najarian JS, Kaufmant DB, Fryd DS, Mc Hugh L, Mauer SM, Remsay RC, Kennedy WR, Navarro X., Goetz FC, Sutherland DER: Long-term survival following kidney transplantation in 100 Type I diabetic patients. Transplantation 47: 106–113, 1989.

    Article  PubMed  CAS  Google Scholar 

  73. Kelly JJ, Walker RG, Kinceid-Smith P: De novo diabetic nodular glomerulosclerosis in renal allograft. Transplantation 53: 688–689, 1992.

    Article  PubMed  CAS  Google Scholar 

  74. Innes A, Pol CR, Deunis MJ, Ryan JJ, Morgan AG, Burolen RR: Posttransplant erythrocytosis and immunosuppression with cyclosporin: a case control study. Nephrol Dial Transplant 6: 588–591, 1991.

    Article  PubMed  CAS  Google Scholar 

  75. Wolff M, Jelkmann W: Erythropoiesis and erythropoietin levels in renal transplant recipients. Klin Wochensch 69: 53–58, 1991.

    Article  CAS  Google Scholar 

  76. Hammond D, Winnick S: Paraneoplastic erythrocytosis and ectopic erythropoietins. Ann N Y Acad Sei 230: 219–227, 1974.

    Article  CAS  Google Scholar 

  77. Reil K, Koziak K, Jarzyto I, Lao M, Gaciong Z: Correction of posttransplant erythrocytosis with enalapril. Transplant Int, in press.

    Google Scholar 

  78. Sauron C, Bertoux P, Bertoux F, Alamartine E, Diob N, Broyet C, Hecini J: New insights and treatment in posttransplant polycythemia (erythrocytosis) of renal recipients. Transplant Proc 25: 1032–1033, 1993.

    PubMed  CAS  Google Scholar 

  79. Gaston RS, Julian BA, Barker CV, Diethelm AG, Curtis JJ: Enalapril: safe and effective therapy for posttransplant erythrocytosis. Transplant Proc 25: 1029–1031, 1993.

    PubMed  CAS  Google Scholar 

  80. Conlon P, Fawell J, Donohoe J, Carmody M, Walsche JJ: The beneficial effect of enalapril on erythrocytosis after renal transplantation. Transplantation 56: 217–219, 1993.

    Article  PubMed  CAS  Google Scholar 

  81. Brunner HR: ACE inhibitors in renal disease. Kidney Int 42: 463–479, 1992.

    Article  PubMed  CAS  Google Scholar 

  82. Hermans MP, Brichard SM, Colin I, Borgies P, Ketelslegers JM, Lambert AE: Long-term reduction of microalbuminuria after 3 years of angiotensin-converting enzyme inhibitors by Perindopril in hypertensive insulin-treated diabetic patients. Am J Med 92 (Suppl 4B): 102S - 107S, 1992.

    Article  PubMed  CAS  Google Scholar 

  83. Bromberg JS, Alfrey EJ, Barker CF, Chavin KD, Dafoe DC, Holland T, Noji A, Perloff LJ, Zellers LA, Grossman RA: Adrenal suppression and steroid supplementation in renal transplant recipients. Transplantation 51: 385–390, 1991.

    Article  PubMed  CAS  Google Scholar 

  84. Handschumacher RE: Immunosuppressive agents. In: AG Goodman, TW Rail, AS Nies, P Toylor, eds, The pharmacological Basis of Therapeutics. Pergamon Press, New York, p 14–1276, 1991.

    Google Scholar 

  85. Rota S, Rembaldi A, Gaspari F, Noris M, Daina E, Benigni A, Aerna A, Donadelli R, Remuzzi G, Garattini S: Methyl-prednisolone dosage effects on peripheral lymphocyte sub-populations and eicosanoid synthesis. Kidney Int 42:981–990

    Google Scholar 

  86. Haynes RC: Adrenocorticotropic hormone: adrenocortical steroids and their synthetic analogs: inhibitors of the synthesis and actions of adrenocortical hormones. In: AG Goodman, TW Rail, SA Nies, P Taylor, eds, The Pharmacological Basis of Therapeutics. Pergamon Press, New York, p 14–1276, 1991.

    Google Scholar 

  87. Norman DJ: Antilymphocyte antibodies in the treatment of allograft rejection: targets, mechanisms of action, monitoring and efficacy. Semin Nephrol 12: 315–324, 1992.

    PubMed  CAS  Google Scholar 

  88. Leimenstoll G, Zabel P, Schroeder P, Schlaak M, Nieder-mayer W: Suppression of OKT-3-induced Tumor Necrosis Factor Alfa formation by Pentoxifylline in renal transplant recipients. Transplant Proc 25: 561–563, 1993.

    PubMed  CAS  Google Scholar 

  89. Kreis H: Antilymphocyte globulin in kidney transplantation. Kidney Int 42:S-188-S-192,1992.

    Google Scholar 

  90. Shihab F, Barry JM, Bennet WM, Mayer MM, Norman DJ: Cytokine-related encephalopathy induced by OKT-3: incidence and predisposing factors. Transplant Proc 25:564–565

    Google Scholar 

  91. Berge RJM, Reasveld MHM, van Diepen FNJ, Hack CE: Activation of coagulation and fibrinolysis during treatment with OKT-3. Transplant Proc 25: 566–567, 1993.

    PubMed  Google Scholar 

  92. Alegre ML, Gasteldello K, Abramowicz D, Kiunaert P, Vereestreeten P, De Pauw L, Vandenebelle P, Moser M, Leo O, Goldmen M: Evidence that pentoxifylline reduces anti- CD3 monoclonal antibody induced cytokine release syndrome. Transplantation 52: 674–679, 1991.

    Article  PubMed  CAS  Google Scholar 

  93. Janssen F, Van Damme-Lombaerts R, Van Dyck M, Hall M, Proesmans W, Goos G, Kinnaert P: Effects of recombinant human growth hormone on graft function in renal transplanted children and adoltescents: three-year experience of a Belgian study group. Transplant Proc 25: 1049–1050, 1993.

    PubMed  CAS  Google Scholar 

  94. Van Dap C, Jobs KL, Donohoue PA, Bock GH, Fivush BA, Hormau WE: Accelerated growth rates in children treated with hormone after renal transplantation. J Pediatr 120: 244–250, 1992.

    Article  Google Scholar 

  95. Neberg G, Nilsson B, Hallste G, Haljamac V, Norden G, Blohme I: Renal transplantation in elderly patients: survival and complications. Transplant Proc 25: 1062–1063, 1993.

    Google Scholar 

  96. Schulak JA, Mayes JT, Jonston KH, Hricik DE: Kidney transplantation in patients aged sixty years and older. Surgery 108: 7–733, 1990.

    Google Scholar 

  97. Salmela KT, Kyllonen LE J, Holmberg Ch, Gronhagen-Riska C: Impaired renal function after pregnancy in renal transplant recipients. Transplantation 56: 1372–1375, 1993.

    Article  PubMed  CAS  Google Scholar 

  98. Bumgardner GL, Matas AJ: Transplantation and pregnancy. Transplantation Rev 6: 139–162, 1992.

    Article  Google Scholar 

  99. Tubular and Metabolic Dysfunction Following Transplantation 1

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Immunotherapy The Transplantation Institute, School of Medicine, Warsaw, Nowogrodzka 59, 02006, Poland

    Liliana Gradowska M.D. (Professor of Medicine, Chief)

  2. The Transplantation Institute, School of Medicine, Warsaw, Nowogrodzka 59, 02006, Poland

    Leszek Paczek M.D. (Associate Professor of Medicine)

Authors
  1. Liliana Gradowska M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leszek Paczek M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Wadi N. Suki M.D. Shaul G. Massry M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Gradowska, L., Paczek, L. (1998). Tubular and Metabolic Dysfunction Following Transplantation. In: Suki, W.N., Massry, S.G. (eds) Suki and Massry’s THERAPY OF RENAL DISEASES AND RELATED DISORDERS. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-6632-5_66

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-6632-5_66

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-6634-9

  • Online ISBN: 978-1-4757-6632-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation